Tamoxifen for nodal recurrence of serous borderline ovarian tumour - a case report

他莫昔芬治疗浆液性交界性卵巢肿瘤淋巴结复发——病例报告

阅读:1

Abstract

BACKGROUND: Serous borderline ovarian tumours (SBTs) are rare epithelial neoplasms typically associated with excellent long-term survival. Most recurrences occur within the first decade and are limited to the peritoneum. Nodal recurrence after several decades is exceedingly rare. Hormonal therapy is well-established in low-grade serous carcinoma (LGSC), but its role in borderline tumours remains undefined. CASE PRESENTATION: We describe the case of a 68-year-old woman with a history of advanced stage serous borderline ovarian tumour, previously treated surgically in the 1980s. After 37 years of disease-free survival, she presented with abdominopelvic pain and was found to have biopsy-confirmed recurrence in multiple nodal regions, including bilateral external iliac and mesenteric lymph nodes. Surgical debulking was performed, confirming SBT. The surgery was complicated by a left external iliac vein injury. Postoperatively, the course was complicated by extensive bilateral deep vein thromboses requiring long-term anticoagulation, as well as a left inguinal lymphocele. She subsequently developed progression in the right external iliac nodes eight months later. Due to surgical complexity, further resection was not pursued, and the patient was initiated on hormonal therapy with Tamoxifen. Follow-up imaging demonstrated partial response. CONCLUSION: This case highlights the rare phenomenon of late nodal recurrence in borderline ovarian tumours and illustrates the potential role of hormonal therapy in selected cases where surgery is no longer feasible.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。